[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE68916424D1 - Pasteurella-impfstoff. - Google Patents

Pasteurella-impfstoff.

Info

Publication number
DE68916424D1
DE68916424D1 DE68916424T DE68916424T DE68916424D1 DE 68916424 D1 DE68916424 D1 DE 68916424D1 DE 68916424 T DE68916424 T DE 68916424T DE 68916424 T DE68916424 T DE 68916424T DE 68916424 D1 DE68916424 D1 DE 68916424D1
Authority
DE
Germany
Prior art keywords
toxin
analog
detoxified
pasteurella multocida
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68916424T
Other languages
English (en)
Other versions
DE68916424T2 (de
Inventor
Foged Niels Taekker
Svend Petersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STATENS VETERINAERE SERUMLABOR
Intervet International BV
Original Assignee
STATENS VETERINAERE SERUMLABOR
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STATENS VETERINAERE SERUMLABOR, Intervet International BV filed Critical STATENS VETERINAERE SERUMLABOR
Publication of DE68916424D1 publication Critical patent/DE68916424D1/de
Application granted granted Critical
Publication of DE68916424T2 publication Critical patent/DE68916424T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1242—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/832—Drug, bio-affecting and body treating compositions involving bacterial toxin that has modified amino acid sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE68916424T 1988-04-12 1989-04-11 Pasteurella-impfstoff. Expired - Lifetime DE68916424T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK199588A DK199588D0 (da) 1988-04-12 1988-04-12 Vaccine
PCT/DK1989/000084 WO1989009617A1 (en) 1988-04-12 1989-04-11 A pasteurella vaccine

Publications (2)

Publication Number Publication Date
DE68916424D1 true DE68916424D1 (de) 1994-07-28
DE68916424T2 DE68916424T2 (de) 1994-11-10

Family

ID=8109323

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68916424T Expired - Lifetime DE68916424T2 (de) 1988-04-12 1989-04-11 Pasteurella-impfstoff.

Country Status (8)

Country Link
US (2) US5369019A (de)
EP (1) EP0409895B1 (de)
AT (1) ATE107516T1 (de)
AU (1) AU3532089A (de)
DE (1) DE68916424T2 (de)
DK (1) DK199588D0 (de)
IE (1) IE64033B1 (de)
WO (1) WO1989009617A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK199588D0 (da) * 1988-04-12 1988-04-12 Nordisk Droge & Kemikalie Vaccine
AU8195391A (en) * 1990-06-13 1992-01-07 Smithkline Beecham Corporation Pasteurella multocida toxoid vaccines
DK120792D0 (da) * 1992-09-30 1992-09-30 Bioteknologisk Inst Protein
EP0668779A4 (de) * 1992-11-06 1996-08-21 Univ Minnesota Impstoff zum Shutz gegen Pasteurellose - Infektion durch P.multocida.
GB0204387D0 (en) * 2002-02-26 2002-04-10 Secr Defence Screening process
WO2005123120A1 (en) * 2004-06-16 2005-12-29 Smart Drug Systems Inc. Sustained release vaccine composition
CN1736479A (zh) 2004-08-20 2006-02-22 简茂盛 猪进行性萎缩性鼻炎的预防、治疗与检测
CN101496899B (zh) * 2004-08-20 2011-08-24 简茂盛 猪进行性萎缩性鼻炎的预防、治疗与检测
TWI285647B (en) * 2004-08-20 2007-08-21 Univ Nat Chunghsing Prevention, treatment and detection of porcine progressive atrophic rhinitis
KR101699245B1 (ko) * 2015-12-21 2017-02-13 주식회사 인트론바이오테크놀로지 신규한 파스튜렐라 멀토시다 박테리오파지 Ｐａｓ-ＭＵＰ-1 및 이의 파스튜렐라 멀토시다 균 증식 억제 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293545A (en) * 1980-03-31 1981-10-06 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria vaccines
NL8200392A (nl) * 1982-02-03 1983-09-01 Duphar Int Res Werkwijze ter bereiding van een immunogeen van pasteurella multocida.
SE8205892D0 (sv) * 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
DK199588D0 (da) * 1988-04-12 1988-04-12 Nordisk Droge & Kemikalie Vaccine

Also Published As

Publication number Publication date
DK199588D0 (da) 1988-04-12
ATE107516T1 (de) 1994-07-15
US6110470A (en) 2000-08-29
WO1989009617A1 (en) 1989-10-19
EP0409895A1 (de) 1991-01-30
US5369019A (en) 1994-11-29
IE891151L (en) 1989-10-12
EP0409895B1 (de) 1994-06-22
DE68916424T2 (de) 1994-11-10
IE64033B1 (en) 1995-06-28
AU3532089A (en) 1989-11-03

Similar Documents

Publication Publication Date Title
FI883876A0 (fi) Menetelmä rokotteen valmistamiseksi streptokokki-infektioita vastaan
HU9203098D0 (en) Living vaccine
MX9703017A (es) Inmunizacion oral con plantas transgenicas.
ATE359370T1 (de) Heterologe antigene in stämmen zur impfung mit lebendzellen
ATE127345T1 (de) Stressproteine und verwendungen dafür.
FI101632B1 (fi) Menetelmä Bordetella pertussis-toksiinin alayksikön analogien valmistamiseksi ja niitä koodaavia rekombinantti-DNA-molekyylejä
DE68916424D1 (de) Pasteurella-impfstoff.
DK341679A (da) Vaccine mod streptokokker og fremgangsmaade til fremstilling deraf
ATE149569T1 (de) Verfahren zur herstellung von impfstoffen oder toxoiden
GB1492596A (en) Tetanus toxoid and process for its manufacture
IE810618L (en) Pasteurella vaccines
AU601415B2 (en) A process for the purification, solubilization and/or detoxification of protein antigens of bacteria of the bordetella genus using a carbonate buffer and an acellular anti-whooping cough vaccine
Moskophidis et al. Molecular characterization of glycoprotein antigens on surface of Treponema pallidum: comparison with nonpathogenic Treponema phagedenis biotype Reiter
SE8205247L (sv) Fiskvacciner
DK230890A (da) Dna-fragment, der koder for et pasteurella multocida-toxin eller for en subsekvens eller analog deraf, ekspressionsvektor, der omfatter dna-fragmentet, mikroorganisme, der udtrykker dette, fremgangsmaade til fremstilling af et pasteurella-multocida-toxin, diagnostisk middel samt anvendelse heraf, vaccine indeholdende et pasteurella-multocida-toxinderivat, anvendelse af pasteurella multocida-t m.m.
KR890000106A (ko) 원생성 기생충 예방용 백신
GB9027901D0 (en) Acellular vaccine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition